Review



ad 169 hcmv strain  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    ATCC ad 169 hcmv strain
    Ad 169 Hcmv Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ad 169 hcmv strain/product/ATCC
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ad 169 hcmv strain - by Bioz Stars, 2024-12
    94/100 stars

    Images



    Similar Products

    94
    ATCC ad 169 hcmv strain
    Ad 169 Hcmv Strain, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ad 169 hcmv strain/product/ATCC
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    ad 169 hcmv strain - by Bioz Stars, 2024-12
    94/100 stars
      Buy from Supplier

    86
    ATCC hcmv strain ad 169 atcc vr 538d
    Hcmv Strain Ad 169 Atcc Vr 538d, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcmv strain ad 169 atcc vr 538d/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    hcmv strain ad 169 atcc vr 538d - by Bioz Stars, 2024-12
    86/100 stars
      Buy from Supplier

    86
    ATCC virus strains human cytomegalovirus ad 169 atcc vr
    Virus Strains Human Cytomegalovirus Ad 169 Atcc Vr, supplied by ATCC, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/virus strains human cytomegalovirus ad 169 atcc vr/product/ATCC
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    virus strains human cytomegalovirus ad 169 atcc vr - by Bioz Stars, 2024-12
    86/100 stars
      Buy from Supplier

    90
    ATCC hcmv strain ad 169
    Quality control for breast carcinomas and fibroadenomas. Multiplex PCR for GADPH. ( A ) Lines 1−9 and 19−26 breast carcinomas; 10−18 fibroadenomas. ( B ) Lines 27, 37−45 breast carcinomas; 19−30, 46 and 47 fibroadenomas. Base pairs (bp); control positive (+), HCMV strain <t>AD-169</t> (ATCC® VR-583); control negative (−), DNA white blood cells from healthy individual (blood donor) and reaction mix without DNA.
    Hcmv Strain Ad 169, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcmv strain ad 169/product/ATCC
    Average 90 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    hcmv strain ad 169 - by Bioz Stars, 2024-12
    90/100 stars
      Buy from Supplier

    86
    Advanced Biotechnologies Inc hcmv ad 169 strain purified viral lysate
    Quality control for breast carcinomas and fibroadenomas. Multiplex PCR for GADPH. ( A ) Lines 1−9 and 19−26 breast carcinomas; 10−18 fibroadenomas. ( B ) Lines 27, 37−45 breast carcinomas; 19−30, 46 and 47 fibroadenomas. Base pairs (bp); control positive (+), HCMV strain <t>AD-169</t> (ATCC® VR-583); control negative (−), DNA white blood cells from healthy individual (blood donor) and reaction mix without DNA.
    Hcmv Ad 169 Strain Purified Viral Lysate, supplied by Advanced Biotechnologies Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcmv ad 169 strain purified viral lysate/product/Advanced Biotechnologies Inc
    Average 86 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    hcmv ad 169 strain purified viral lysate - by Bioz Stars, 2024-12
    86/100 stars
      Buy from Supplier

    94
    ATCC human cytomegalovirus hcmv strains ad 169
    Quality control for breast carcinomas and fibroadenomas. Multiplex PCR for GADPH. ( A ) Lines 1−9 and 19−26 breast carcinomas; 10−18 fibroadenomas. ( B ) Lines 27, 37−45 breast carcinomas; 19−30, 46 and 47 fibroadenomas. Base pairs (bp); control positive (+), HCMV strain <t>AD-169</t> (ATCC® VR-583); control negative (−), DNA white blood cells from healthy individual (blood donor) and reaction mix without DNA.
    Human Cytomegalovirus Hcmv Strains Ad 169, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human cytomegalovirus hcmv strains ad 169/product/ATCC
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    human cytomegalovirus hcmv strains ad 169 - by Bioz Stars, 2024-12
    94/100 stars
      Buy from Supplier

    99
    ATCC hcmv ad169
    Quality control for breast carcinomas and fibroadenomas. Multiplex PCR for GADPH. ( A ) Lines 1−9 and 19−26 breast carcinomas; 10−18 fibroadenomas. ( B ) Lines 27, 37−45 breast carcinomas; 19−30, 46 and 47 fibroadenomas. Base pairs (bp); control positive (+), HCMV strain <t>AD-169</t> (ATCC® VR-583); control negative (−), DNA white blood cells from healthy individual (blood donor) and reaction mix without DNA.
    Hcmv Ad169, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hcmv ad169/product/ATCC
    Average 99 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    hcmv ad169 - by Bioz Stars, 2024-12
    99/100 stars
      Buy from Supplier

    94
    ATCC viral strain hcmv ad 169
    Inhibition activity of dendrimers against HCMV <t>AD−169</t> . Plaque reduction assays were performed in MRC-5 cells for 6 days treatments. MRC-5 cells were pre-treated for 1 h at 37 ºC with increased concentrations of G1-S4, G2-S16 and G2-S24P PCDs (1, 5 and 10 µM) and infected with 60 PFU at 37 ºC. Plaques were counted after 6 days with a methylene blue dye. Percentage of infection is represented as the number of plaques in treatments in regard of the control of infection. CI, Control of Infection; NT, non-treated control. The mean values (mean ± SD) of at least four independent experiments are shown (* p < 0.05; ** p < 0.005; *** p < 0.001)
    Viral Strain Hcmv Ad 169, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/viral strain hcmv ad 169/product/ATCC
    Average 94 stars, based on 1 article reviews
    Price from $9.99 to $1999.99
    viral strain hcmv ad 169 - by Bioz Stars, 2024-12
    94/100 stars
      Buy from Supplier

    Image Search Results


    Quality control for breast carcinomas and fibroadenomas. Multiplex PCR for GADPH. ( A ) Lines 1−9 and 19−26 breast carcinomas; 10−18 fibroadenomas. ( B ) Lines 27, 37−45 breast carcinomas; 19−30, 46 and 47 fibroadenomas. Base pairs (bp); control positive (+), HCMV strain AD-169 (ATCC® VR-583); control negative (−), DNA white blood cells from healthy individual (blood donor) and reaction mix without DNA.

    Journal: Infectious Agents and Cancer

    Article Title: Is human cytomegalovirus associated with breast cancer progression?

    doi: 10.1186/1750-9378-8-12

    Figure Lengend Snippet: Quality control for breast carcinomas and fibroadenomas. Multiplex PCR for GADPH. ( A ) Lines 1−9 and 19−26 breast carcinomas; 10−18 fibroadenomas. ( B ) Lines 27, 37−45 breast carcinomas; 19−30, 46 and 47 fibroadenomas. Base pairs (bp); control positive (+), HCMV strain AD-169 (ATCC® VR-583); control negative (−), DNA white blood cells from healthy individual (blood donor) and reaction mix without DNA.

    Article Snippet: Positive control was done with HCMV strain AD-169 (ATCC VR-583).

    Techniques: Multiplex Assay

    Inhibition activity of dendrimers against HCMV AD−169 . Plaque reduction assays were performed in MRC-5 cells for 6 days treatments. MRC-5 cells were pre-treated for 1 h at 37 ºC with increased concentrations of G1-S4, G2-S16 and G2-S24P PCDs (1, 5 and 10 µM) and infected with 60 PFU at 37 ºC. Plaques were counted after 6 days with a methylene blue dye. Percentage of infection is represented as the number of plaques in treatments in regard of the control of infection. CI, Control of Infection; NT, non-treated control. The mean values (mean ± SD) of at least four independent experiments are shown (* p < 0.05; ** p < 0.005; *** p < 0.001)

    Journal: Journal of Nanobiotechnology

    Article Title: Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents

    doi: 10.1186/s12951-021-00809-4

    Figure Lengend Snippet: Inhibition activity of dendrimers against HCMV AD−169 . Plaque reduction assays were performed in MRC-5 cells for 6 days treatments. MRC-5 cells were pre-treated for 1 h at 37 ºC with increased concentrations of G1-S4, G2-S16 and G2-S24P PCDs (1, 5 and 10 µM) and infected with 60 PFU at 37 ºC. Plaques were counted after 6 days with a methylene blue dye. Percentage of infection is represented as the number of plaques in treatments in regard of the control of infection. CI, Control of Infection; NT, non-treated control. The mean values (mean ± SD) of at least four independent experiments are shown (* p < 0.05; ** p < 0.005; *** p < 0.001)

    Article Snippet: The viral strain HCMV AD−169 (ATCC VR-538) was expanded and titrated in MRC-5 cell line by plaque assay with serial dilutions.

    Techniques: Inhibition, Activity Assay, Infection

    Representative images of HCMV AD - 169 plaques in treatments with G2-S16 dendrimer. a Optical and b confocal representative images of MRC-5 cells. Briefly, MRC-5 cells were plated and treated with G2-S16 dendrimer (10 µM) for 1 h and infected with 60 PFU for 2 h at 37 ºC. After 6 days incubation a MRC-5 cells were dyed with methylene blue and images were taken on a DMIL Leica microscope at 4X augment. b MRC-5 cells were treated with HCMVpp65 ALEXA FLUOR® 488 Antibody Conjugated for viral particles visualization, phalloidin ALEXA FLUOR® 555 Conjugated and DAPI for membrane and nucleus localization. NT: non-treated; CI: control of infection

    Journal: Journal of Nanobiotechnology

    Article Title: Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents

    doi: 10.1186/s12951-021-00809-4

    Figure Lengend Snippet: Representative images of HCMV AD - 169 plaques in treatments with G2-S16 dendrimer. a Optical and b confocal representative images of MRC-5 cells. Briefly, MRC-5 cells were plated and treated with G2-S16 dendrimer (10 µM) for 1 h and infected with 60 PFU for 2 h at 37 ºC. After 6 days incubation a MRC-5 cells were dyed with methylene blue and images were taken on a DMIL Leica microscope at 4X augment. b MRC-5 cells were treated with HCMVpp65 ALEXA FLUOR® 488 Antibody Conjugated for viral particles visualization, phalloidin ALEXA FLUOR® 555 Conjugated and DAPI for membrane and nucleus localization. NT: non-treated; CI: control of infection

    Article Snippet: The viral strain HCMV AD−169 (ATCC VR-538) was expanded and titrated in MRC-5 cell line by plaque assay with serial dilutions.

    Techniques: Infection, Incubation, Microscopy

    Activity of PCDs at cell membrane-virus attachment. Plaque reduction assays were performed in MRC-5 cells for 6 days treatments. MRC-5 cells were pre-cooled at 4 ºC and pre-treated for 1 h at 4 ºC with increased concentrations of G1-S4, G2-S16 and G2-S24P PCDs (1, 5 and 10 µM) and infected with 60 PFU at 4 ºC. Plaques were counted after 6 days with a methylene blue dye. Percentage of infection is represented as the number of plaques in treatments in regard of the control of HCMV AD−169 infection. CI: Control of Infection NT = non-treated control. The mean values (mean ± SD) of at least four independent experiments are shown (* p < 0.05; ** p < 0.005; *** p < 0.001)

    Journal: Journal of Nanobiotechnology

    Article Title: Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents

    doi: 10.1186/s12951-021-00809-4

    Figure Lengend Snippet: Activity of PCDs at cell membrane-virus attachment. Plaque reduction assays were performed in MRC-5 cells for 6 days treatments. MRC-5 cells were pre-cooled at 4 ºC and pre-treated for 1 h at 4 ºC with increased concentrations of G1-S4, G2-S16 and G2-S24P PCDs (1, 5 and 10 µM) and infected with 60 PFU at 4 ºC. Plaques were counted after 6 days with a methylene blue dye. Percentage of infection is represented as the number of plaques in treatments in regard of the control of HCMV AD−169 infection. CI: Control of Infection NT = non-treated control. The mean values (mean ± SD) of at least four independent experiments are shown (* p < 0.05; ** p < 0.005; *** p < 0.001)

    Article Snippet: The viral strain HCMV AD−169 (ATCC VR-538) was expanded and titrated in MRC-5 cell line by plaque assay with serial dilutions.

    Techniques: Activity Assay, Infection

    Virucidal activity of G2-S16 or G2-S24P dendrimers against HCMV AD−169 . Plaque reduction assays were performed in MRC-5 cells for 6 days treatments. G2-S16 or G2-S24P dendrimer at 10 µM was incubated with 60 PFU for 2 h at 37 ºC. By several centrifugations at 12,000 RPM virus was pelleted, resuspended in fresh DMEM and added to MRC-5 cells for plaque reduction assays. Plaques were counted after 6 days with a methylene blue dye. Percentage of HCMV AD−169 infection is represented as the number of plaques in treatments in regard of the control of infection. Triton X-100 was used as a positive control of virus membrane disruption. CI: Control of Infection, NT: non-treated control. The mean values (mean ± SD) of at least four independent experiments are shown (* p < 0.05; ** p < 0.005; *** p < 0.001)

    Journal: Journal of Nanobiotechnology

    Article Title: Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents

    doi: 10.1186/s12951-021-00809-4

    Figure Lengend Snippet: Virucidal activity of G2-S16 or G2-S24P dendrimers against HCMV AD−169 . Plaque reduction assays were performed in MRC-5 cells for 6 days treatments. G2-S16 or G2-S24P dendrimer at 10 µM was incubated with 60 PFU for 2 h at 37 ºC. By several centrifugations at 12,000 RPM virus was pelleted, resuspended in fresh DMEM and added to MRC-5 cells for plaque reduction assays. Plaques were counted after 6 days with a methylene blue dye. Percentage of HCMV AD−169 infection is represented as the number of plaques in treatments in regard of the control of infection. Triton X-100 was used as a positive control of virus membrane disruption. CI: Control of Infection, NT: non-treated control. The mean values (mean ± SD) of at least four independent experiments are shown (* p < 0.05; ** p < 0.005; *** p < 0.001)

    Article Snippet: The viral strain HCMV AD−169 (ATCC VR-538) was expanded and titrated in MRC-5 cell line by plaque assay with serial dilutions.

    Techniques: Activity Assay, Incubation, Infection, Positive Control

    Time of addition of G2-S16 or G2-S24P dendrimer and their combinations with ganciclovir. Plaque reduction assays were performed in MRC-5 cells for 6 days. MRC-5 cells were seeded, infected with 60 PFU and treated at different time points (0, 24, 48, 72 and 96 h post-infection) with either a ganciclovir, G2-S16 dendrimer and G2-S16 dendrimer + ganciclovir combination b ganciclovir, G2-S24P dendrimer, and G2-S24P + ganciclovir. Plaques were counted after 6 days with a methylene blue dye. Percentage of HCMV AD−169 infection is represented as the number of plaques in treatments in regard of the control of HCMV AD−169 infection. CI: Control of infection, NT: non-treated control. The mean values (mean ± SD) of at least four independent experiments are shown (* p < 0.05; ** p < 0.005; *** p < 0.001)

    Journal: Journal of Nanobiotechnology

    Article Title: Nanotechnology against human cytomegalovirus in vitro: polyanionic carbosilane dendrimers as antiviral agents

    doi: 10.1186/s12951-021-00809-4

    Figure Lengend Snippet: Time of addition of G2-S16 or G2-S24P dendrimer and their combinations with ganciclovir. Plaque reduction assays were performed in MRC-5 cells for 6 days. MRC-5 cells were seeded, infected with 60 PFU and treated at different time points (0, 24, 48, 72 and 96 h post-infection) with either a ganciclovir, G2-S16 dendrimer and G2-S16 dendrimer + ganciclovir combination b ganciclovir, G2-S24P dendrimer, and G2-S24P + ganciclovir. Plaques were counted after 6 days with a methylene blue dye. Percentage of HCMV AD−169 infection is represented as the number of plaques in treatments in regard of the control of HCMV AD−169 infection. CI: Control of infection, NT: non-treated control. The mean values (mean ± SD) of at least four independent experiments are shown (* p < 0.05; ** p < 0.005; *** p < 0.001)

    Article Snippet: The viral strain HCMV AD−169 (ATCC VR-538) was expanded and titrated in MRC-5 cell line by plaque assay with serial dilutions.

    Techniques: Infection